rs140968382
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002292.4(LAMB2):c.4304C>T(p.Pro1435Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000485 in 1,608,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002292.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMB2 | NM_002292.4 | c.4304C>T | p.Pro1435Leu | missense_variant | 27/32 | ENST00000305544.9 | NP_002283.3 | |
LAMB2 | XM_005265127.5 | c.4304C>T | p.Pro1435Leu | missense_variant | 28/33 | XP_005265184.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMB2 | ENST00000305544.9 | c.4304C>T | p.Pro1435Leu | missense_variant | 27/32 | 1 | NM_002292.4 | ENSP00000307156.4 | ||
LAMB2 | ENST00000418109.5 | c.4304C>T | p.Pro1435Leu | missense_variant | 28/33 | 1 | ENSP00000388325.1 | |||
LAMB2 | ENST00000469665.1 | n.613C>T | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000653 AC: 16AN: 245022Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133266
GnomAD4 exome AF: 0.0000364 AC: 53AN: 1456602Hom.: 0 Cov.: 34 AF XY: 0.0000345 AC XY: 25AN XY: 724882
GnomAD4 genome AF: 0.000164 AC: 25AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74450
ClinVar
Submissions by phenotype
Pierson syndrome;C3280113:LAMB2-related infantile-onset nephrotic syndrome Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | 3billion | Sep 20, 2024 | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | ClinVar contains an entry for this variant (Variation ID: 574422). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with LAMB2-related conditions. This variant is present in population databases (rs140968382, gnomAD 0.06%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1435 of the LAMB2 protein (p.Pro1435Leu). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 13, 2024 | - - |
LAMB2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 20, 2022 | The LAMB2 c.4304C>T variant is predicted to result in the amino acid substitution p.Pro1435Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.057% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-49160406-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 10, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at